ProFuse Technology unveils cell line for cultivated meat: PROFUSE-B8

ProFuse Technology, which specializes in creating solutions for muscle growth in the cultivated meat and life science industries, has announced the official launch of PROFUSE-B8, a spontaneously immortalized bovine myoblast cell line available for licensing. This development marks a significant milestone in the cultivated meat industry, introducing a paradigm shift in the efficient cultivation of protein-rich muscle tissue.

Extensively researched and tested over a comprehensive two-year period, the PROFUSE-B8 cell line presents cultivated meat producers with a stable and robust foundation for the development of scalable, repeatable, and cost-competitive production processes. Notably, B8 achieves this without resorting to genetic modification technology, ensuring optimal alignment with consumer preferences and acceptance.

Complementing its groundbreaking attributes, when integrated with the PROFUSE-S1 muscle differentiation media supplement muscle tissue production is accelerated, offering increased efficiency within shorter production times.

ProFuse Technology remains steadfast in its commitment to advancing the cultivated meat sector by providing cutting-edge muscle-related production solutions. Concurrently, the company is actively engaged in the development of additional muscle production-optimized cell lines tailored for chicken, pork, lamb, and fish.

"We are thrilled to introduce PROFUSE-B8 as a transformative solution for the cultivated meat industry," remarked Dr Tamar Eigler-Hirsh, CTO & Co-Founder at ProFuse Technology. "Our dedication to innovation and productivity is evident in the development of this breakthrough cell line, and we are confident it will shape the future of cell based protein production."